OTC:CC - Ocumetics Prepares for a Second Day of Accommodating Intraocular Lens Implantations
(TheNewswire)
Calgary, Alberta – TheNewswire - August 26, 2025 -Ocumetics Technology Corp . (“Ocumetics” or the “Company”)(TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advancedophthalmic technology, is pleased to announce that it has completedthe one-week postoperative examination of the first patients who wereimplanted with the Ocumetics Accommodating Intraocular Lens (the“Ocumetics Lens”). All patients are recovering well, and nocomplications have been observed.
With this important milestone achieved, additionalindividuals are now being recruited to complete the first group ofpatients who will be receive the Ocumetics Lens.
“ This is an exciting and meaningful step forward inour mission to redefine vision correction,” said Dean Burns,President and CEO of Ocumetics Technology Corp. “Early outcomeswith our first patients have been encouraging, allowing us to proceedwith a second day of implantations. The real measure of success, ofcourse, will be seen over the coming weeks when the eyes haverecovered completely from surgery.”
“This moment culminates years of development,”added Dr. Garth Webb, Chief Scientist and Founder of Ocumetics. “The Ocumetics Lens has always been about restoring the full rangeof vision to patients. These first clinical results show that we areon the right path toward making that vision a reality.”
Unlike traditional monofocal or multifocal intraocularlenses, the Ocumetics Lens is designed to use the natural muscularactivity within the eye to focus both distant and near objects clearlywithout glasses or contact lenses followingcataract surgery.
About Ocumetics
Ocumetics Technology Corp. ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)is a Canadian research and product development company that is dedicated to developing advanced visioncorrection solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims totransform the field of ophthalmology with state-of-the-art intraocularlenses and other vision-enhancing technologies.
Ocumetics is in the preclinical study phase of agame-changing technology for the ophthalmic industry. Ocumetics hasdeveloped an intraocular lens that fits within the natural lenscompartment of the eye, potentially to eliminate the need forcorrective lenses. It is designed to allow the eye’s naturalmuscle activity to shift focus from distance to near, providing clearvision at all distances without the help of glasses or contact lenses.
FOR FURTHER INFORMATION, PLEASECONTACT:
Dean Burns Roger Jewett
President and Chief Executive Officer ChiefFinancial Officer
(817) 874-7564 roger.jewett@ocumetics.com
Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKINGINFORMATION: This news release includes certain “forward-lookingstatements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to,statements with respect to the commencement, timing and scope of theresearch and development to be conducted by the Corporation mentionedabove. Forward-looking statements are necessarily based upon anumber of estimates and assumptions that, while considered reasonable,are subject to known and unknown risks, uncertainties, and otherfactors which may cause the actual results and future events to differmaterially from those expressed or implied by such forward-lookingstatements. Such factors include but are not limited to: operationalmatters, historical trends, current conditions and expected futuredevelopments, access to financing as well as other considerations thatare believed to be appropriate in the circumstances. There can be noassurance that such statements will prove to be accurate, as actualresults and future events could differ materially from thoseanticipated in such statements. Accordingly, readers should not placeundue reliance on forward-looking statements. The Corporationdisclaims any intention or obligation to update or revise anyforward-looking statements, whether as a result of new information,future events or otherwise, except as required by law.
Copyright (c) 2025 TheNewswire - All rights reserved.